What’s Hot: Mastering MASH-Specific Therapies That Deliver

Faculty

Sonal Kumar, MD, MPH
Moderator
Director, General Gastroenterology and Hepatology
Director, Innovative Center for Health and Nutrition in Gastroenterology (ICHANGE)
Assistant Professor of Medicine
Weill Cornell Medical College
New York, NY
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Chairman, Global NASH/MASH Council
Washington, DC
Professor and Chairman, Beatty Liver and Obesity Research
Inova Health System
Falls Church, VA

Statement of Need

In this CME Outfitters Snack on metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic-associated steatohepatitis (MASH), expert faculty turn attention to treatment planning for Mr. B, who has been diagnosed with MASH. Discussion centers on evidence-based lifestyle interventions, including nutrition and physical activity, and integrates the latest data on recently approved therapies that are clinically relevant to Mr. B’s case. Faculty also highlight key recommendations from the 2025 American Diabetes Association (ADA) MASLD Guideline, reviewing the liver, cardiometabolic, and cardiorenal effects of other glucose-lowering agents not yet specifically approved for MASLD/MASH. The program concludes with a practical look at the interprofessional care team, emphasizing collaboration among clinicians managing patients with diabetes and MASLD/MASH.

This third of four CME Outfitters Snacks features MASLD/MASH experts Sonal Kumar, MD, and Zobair Younossi, MD.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Identify available MASH-specific therapies appropriate for timely management in concordance with treatment guidelines and care pathways

Financial Support

Supported by an educational grant from Novo Nordisk Inc.

Target Audience

Physicians, nurse practitioners (NPs), physician associates (PAs), nurses, and pharmacists treating patients with MASH

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours (0.075 CEUs) of continuing pharmacy credit (JA0007185-0000-25-097-H01-P).

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

California Residents: Provider approved by the California Board of Registered Nursing, Provider # CEP 15510, for 0.75 Contact Hours.

Physician Assistants (AAPA): 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 10/29/2026. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Kumar reports the following financial relationships:

Advisory Board/Consultant: Boehringer Ingelheim; Gilead Sciences, Inc.; GSK; Intercept Pharmaceuticals; Ipsen; Madrigal Pharmaceuticals; and Novo Nordisk

Grants: Kenetix Group and Madrigal Pharmaceuticals

Speakers Bureau: Boehringer Ingelheim; Gilead Sciences, Inc.; GSK; Intercept Pharmaceuticals; Ipsen; Madrigal Pharmaceuticals; and Novo Nordisk

Dr. Younossi reports the following financial relationships:

Research Support/Consultant: Abbott; Akero Therapeutics, Inc.; Aligos Therapeutics; Boehringer Ingelheim; Bristol Myers Squibb Company; Cymabay Therapeutics, Inc.; GSK; Intercept Pharmaceuticals, Inc.; Ipsen Pharma; Madrigal Pharmaceuticals, Inc.; Merck & Co., Inc; Novo Nordisk; and Siemens

The following individuals have no financial relationships to disclose:

Jeffrey Helfand, DO (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Warren Beckman (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

SN-285-102925-68

What’s Hot: Mastering MASH-Specific Therapies That Deliver
Event Date: 10/29/2025